CRISPR And Cas Genes Market Research Report 2023 Featuring Top Players - Thermo Fisher Scientific, Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Caribou Biosciences - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "CRISPR And Cas Genes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031" report has been added to ResearchAndMarkets.com's offering.

The global CRISPR and Cas genes market is expected to grow significantly in the coming years, with a CAGR of 18.5% during the forecast period of 2023 to 2031.

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

This growth is driven by the increasing demand for gene editing technologies in various applications such as agriculture, pharmaceuticals, and biotechnology.

CRISPR and Cas genes have become one of the most promising tools in the field of genetic engineering, revolutionizing the way we approach gene editing and genetic manipulation.

The pharmaceutical and biotechnology industries are the major contributors to the growth of the CRISPR and Cas genes market. The technology is being used in drug discovery and development, with the potential to treat a wide range of genetic disorders. The agriculture industry is also adopting this technology to improve crop yields and develop disease-resistant crops.

Increasing Demand for Gene Editing Technologies in Pharmaceutical Industry

The pharmaceutical industry is a major driver of the CRISPR and Cas genes market. The technology is being used in drug discovery and development, with the potential to treat a wide range of genetic disorders.

The global gene editing market is expected to reach $9.5 billion by 2025, with the CRISPR/Cas system being the most widely used gene editing technology. Several companies are investing heavily in the development of CRISPR-based therapies, including CRISPR Therapeutics AG, Intellia Therapeutics, and Editas Medicine, among others.

Adoption of CRISPR/Cas Technology in Agriculture

The agriculture industry is also driving the growth of the CRISPR and Cas genes market. The technology is being used to improve crop yields and develop disease-resistant crops.

The global agricultural biotechnology market is expected to cross $55 billion by 2025, with the CRISPR/Cas system being one of the key technologies driving this growth. Companies such as Bayer AG, DuPont Pioneer, and DowDuPont are investing heavily in the development of CRISPR-edited crops.

Rising Prevalence of Genetic Disorders

The rising prevalence of genetic disorders is driving the demand for gene editing technologies such as CRISPR and Cas genes. According to the World Health Organization, genetic disorders affect millions of people worldwide, with an estimated 1 in 20 live births being affected by a genetic disorder.

The CRISPR/Cas system has the potential to treat a wide range of genetic disorders, including sickle cell anemia, cystic fibrosis, and Huntington's disease, among others. Several clinical trials are underway to test the safety and efficacy of CRISPR-based therapies for genetic disorders, which could further drive the growth of the CRISPR and Cas genes market.

Off-Target Effects and Ethical Concerns

One of the major restraints of the CRISPR and Cas genes market is the potential for off-target effects, which can result in unintended and potentially harmful changes to the genome. While the CRISPR/Cas system is highly precise, it is not perfect, and there is still a risk of off-target effects.

This has led to concerns about the safety and ethical implications of using this technology for gene editing. In addition, there are also concerns about the potential misuse of this technology for non-medical purposes, such as enhancing human traits. These concerns could lead to increased regulatory scrutiny and slower adoption of the technology, which could restrain the growth of the CRISPR and Cas genes market.

Market Competition to Intensify during the Forecast Period

The CRISPR and Cas genes market is highly competitive, with several key players operating in the market. Some of the top players in the market include Thermo Fisher Scientific, Inc., Editas Medicine, Inc., CRISPR Therapeutics AG, Intellia Therapeutics, Inc., and Caribou Biosciences, Inc., among others.

These players are focusing on strategic collaborations, partnerships, and mergers and acquisitions to expand their market presence and strengthen their product portfolios.

Furthermore, several key players are investing in research and development activities to develop new and innovative gene editing technologies.

Key questions answered in this report

• What are the key micro and macro environmental factors that are impacting the growth of CRISPR And Cas Genes market?
• What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
• Estimated forecast and market projections up to 2031.
• Which segment accounts for the fastest CAGR during the forecast period?
• Which market segment holds a larger market share and why?
• Are low and middle-income economies investing in the CRISPR And Cas Genes market?
• Which is the largest regional market for CRISPR And Cas Genes market?
• What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
• Which are the key trends driving CRISPR And Cas Genes market growth?
• Who are the key competitors and what are their key strategies to enhance their market presence in the CRISPR And Cas Genes market worldwide?

Company Profiles

• Thermo Fisher Scientific Inc.
• Editas Medicine Inc.
• CRISPR Therapeutics AG
• Intellia Therapeutics Inc.
• Caribou Biosciences Inc.

Market Segmentation

Product

• Kits & Enzymes
• Vector-based Cas
• DNA-free Cas
• Libraries
• Design Tool
• Antibodies
• Others

Service

• Cell Line Engineering
• gRNA Design
• Microbial Gene Editing
• DNA Synthesis

Application

• Biomedical
• Genome Engineering
• Disease Model Studies
• Functional Genomics
• Epigenetics
• Others
• Agricultural

End-use

• Biotechnology & Pharmaceutical Companies
• Academics & Government Research Institutes
• Contract Research Organizations (CROs)

For more information about this report visit https://www.researchandmarkets.com/r/yq41uc

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900